Platelet C4d is associated with acute ischemic stroke and stroke severity

Stroke

Volumn 39, Issue 12, 2008, Pages 3236-3241

  Mehta, Nidhi ^a   Uchino, Ken ^a   Fakhran, Saeed ^a   Sattar, M Abdus ^b   Branstetter, Barton F ^a   Au, Karen ^a   Navratil, Jeannine S ^a   Paul, Barbara ^a   Lee, Melissa ^a   Gallagher, Katie M ^a   Manzi, Susan ^a,b   Ahearn, Joseph M ^a   Kao, Amy H ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c University of Pittsburgh ^*  (United States)

Author keywords

Complement activation; Infarct volume; Ischemic stroke; NIH stroke scale; Platelet; Stroke severity

Indexed keywords

ABCIXIMAB; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C4D; DIPYRIDAMOLE; EPTIFIBATIDE; FIBRINOLYTIC AGENT; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ARTICLE; BRAIN CIRCULATION; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RATING SCALE; THROMBOCYTE; ACUTE DISEASE; BLOOD; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CHEMISTRY; COMORBIDITY; COMPARATIVE STUDY; FIBRINOLYTIC THERAPY; HOSPITALIZATION; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; PATHOLOGY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE DISEASE; AGED; ANTIBODIES, ANTICARDIOLIPIN; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD PLATELETS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; COMORBIDITY; COMPLEMENT C4B; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLATELET AGGREGATION INHIBITORS; RHEUMATIC DISEASES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY;

EID: 58149333274     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.514687     Document Type: Article

References (23)

1. Navratil JS, Manzi S, Kao AH, Krishnaswami S, Liu CC, Ruffing MJ, Shaw PS, Nilson AC, Dryden ER, Johnson JJ, Ahearn JM. Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum. 2006;54:670-674.
2. Di Napoli M. Systemic complement activation in ischemic stroke. Stroke. 2001;32:1443-1448.
3. Atkinson C, Zhu H, Qiao F, Varela JC, Yu J, Song H, Kindy MS, Tomlinson S. Complement-dependent P-selectin expression and injury following ischemic stroke. J Immunol. 2006;177:7266-7274.
4. Mocco J, Mack WJ, Ducruet AF, Sosunov SA, Sughrue ME, Hassid BG, Nair MN, Laufer I, Komotar RJ, Claire M, Holland H, Pinsky DJ, Connolly ES Jr. Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res. 2006;99:209-217.
5. Pedersen ED, Waje-Andreassen U, Vedeler CA, Aamodt G, Mollnes TE. Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol. 2004;137:117-122.
6. Mocco J, Wilson D, Komotar R, Sughrue M, Coates K, Sacco R, Elkind M, Connolly E. Alterations in plasma complement levels after human ischemic stroke. Neurosurgery. 2006;59:28-33.
7. Figueroa E, Gordon LE, Feldhoff PW, Lassiter HA. The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats. Neurosci Lett. 2005;380:48-53.
8. Imm MD, Feldhoff PW, Feldhoff RC, Lassiter HA. The administration of complement component C9 augments post-ischemic cerebral infarction volume in neonatal rats. Neurosci Lett. 2002;325:175-178.
9. D'Ambrosio A, Pinsky D, Connolly E. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection. Mol Med. 2001;7:367-382.
10. del Conde I, Cruz MA, Zhang H, Lopez JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med. 2005;201:871-879.
11. De Simoni M, Storini C, Barba M, Catapano L, Arabia A, Rossi E, Bergamaschini L. Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J Cereb Blood Flow Metab. 2003;23:232-239.
12. Salter JW, Krieglstein CF, Issekutz AC, Granger DN. Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation. Am J Physiol Gastrointest Liver Physiol. 2001;281: G1432-G1439.
13. Zhang Z-g, Zhang Q-z, Cheng Y-n, Ji S-l, Du G-h. Antagonistic effects of ultra-low-molecular-weight heparin against cerebral ischemia/ reperfusion injury in rats. Pharmacol Res. 2007;56:350-355.
14. Sakurai-Yamashita Y, Kinugawa H, Niwa M. Neuroprotective effect of pentosan polysulphate on ischemia-related neuronal death of the hippocampus. Neurosci Lett. 2006;409:30-34.
15. Kingma JG, Plante S, Bogaty P. Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion. J Am Coll Cardiol. 2000;36:2317-2324.
16. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, III. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute stroke Treatment. Stroke. 1993;24:35-41.
17. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
18. Huang J, Choudhri TF, Winfree CJ, McTaggart RA, Kiss S, Mocco J, Kim LJ, Protopsaltis TS, Zhang Y, Pinsky DJ, Connolly ES Jr, Feuerstein GZ. Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke editorial comment. Stroke. 2000;31:3047-3053.
19. Brey RL, Stallworth CL, McGlasson DL, Wozniak MA, Wityk RJ, Stern BJ, Sloan MA, Sherwin R, Price TR, Macko RF, Johnson CJ, Earley CJ, Buchholz DW, Hebel JR, Kittner SJ, Tuhrim S, Levine SR. Antiphospholipid antibodies and stroke in young women * editorial comment. Stroke. 2002;33:2396-2401.
20. Brey R, Hart R, Sherman D, Tegeler C. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology. 1990;40:1190-1196.
21. Nencini P, Baruffi M, Abbate R, Massai G, Amaducci L, Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke. 1992;23:189-193.
22. Toschi V, Motta A, Castelli C, Paracchini ML, Zerbi D, Gibelli A. High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke. 1998;29: 1759-1764.
23. Singh K, Gaiha M, Shome D, Gupta V, Anuradha S. The association of antiphospholipid antibodies with ischaemic stroke and myocardial infarction in young and their correlation: a preliminary study. J Assoc Physicians India. 2001;49:527-529.